GLP-1-based pharmacotherapies
1 paper2 findings
Outcomes
1Fat mass and fat-free or lean mass
downin humans1
1 study
Fat mass and fat-free or lean mass
downin humans1
GLP-1-based pharmacotherapies decrease fat mass and fat-free or lean mass in humans.
“Clinical studies reported greater reductions in fat mass than in fat-free or lean mass, neither of which represents skeletal muscle exclusively.”
Reviewclinical studies reviewed
Nutrients1 Oct 2026
Associations
1Muscle quantity and function
mixedin humans1
1 study
Muscle quantity and function
mixedin humans1
GLP-1-based pharmacotherapies are associated with muscle quantity and function in humans.
“Direct muscle and functional outcomes were assessed in few studies and yielded mixed results.”
Reviewclinical studies reviewedskeletal muscle
Nutrients1 Oct 2026